If I may add one quick comment. It's almost a good news story that I can't give you a list of every company and how many dollars they received and how they benefited, because what it means—to Dr. Neame's point—is that everyone is working in collaboration.
I can point to a company of ours in Quebec, Medicago, which we mentioned in the opening comments. It identified a candidate vaccine in 20 days from the virus first being identified here in Canada. In British Columbia, we have Eli Lilly, one of our member companies working with AbCellera. They have taken advantage of a great deal of funding to work on the antibody side of this particular situation.
We could go on with a list of where our companies have benefited. Our website, actually, keeps a daily and weekly update of all of the projects under way, if you'd like to have a look at those. We're very grateful that the government has really acknowledged the important role that the life sciences play at this particular time, and has put money behind that.